New Technology– category –
-
Modern Dispersions Partners with HydroGraph to Scale Fractal Graphene Production, Boosting Material Strength by 20-70%
PR Newswire (via HydroGraph) USA Overview Modern Dispersions Inc. (MDI) has become a certified compounding partner for HydroGraph, significantly expanding commercial-scale fractal graphene masterbatch production in North America. MDI’s d... -
Photoactivated Nanomaterials Achieve 99% Bacterial Reduction in Antibiotic-Resistant Wounds, Revolutionizing Chronic Wound Care
ScienceDaily USA Overview Scientists have developed a novel smart wound care system utilizing photoactivated nanomaterials that effectively treats antibiotic-resistant chronic wounds. This innovative approach targets and eradicates resis... -
Cell and Gene Therapy’s Next Frontier: Overcoming Manufacturing, Commercial, and Clinical Infrastructure Challenges Beyond Scientific Discovery
Drug Discovery News USA Overview The primary challenge for cell and gene therapies is shifting from scientific discovery to building robust manufacturing, commercial, and clinical infrastructure. Issues like insufficient durability due t... -
Medyra Health Bolsters Therapeutic Development and Evaluation by Leveraging Real-World Evidence (RWE)
Medyra Health USA Overview Medyra Health outlines its RWE-focused therapeutic approach, emphasizing the generation of high-quality real-world evidence to enhance therapy evaluation and development. The company specializes in RWE study de... -
Penn Medicine Leads Cell and Gene Therapy Field, Pioneering Foundational Research for CAR T-Cell Therapies
Penn Medicine USA Overview Penn Medicine highlights its profound expertise in cell and gene therapies, including its foundational work in CAR T-cell therapy. The institution explains how these "biologics" target the root cause of illness... -
Alliance for Cancer Gene Therapy Appoints Jonathan S. Doctor and John Neamonitis to Board of Directors, Strengthening Research Funding Mission
PR Newswire USA Overview The Alliance for Cancer Gene Therapy (ACGT) announced the appointment of Jonathan S. Doctor and John Neamonitis to its Board of Directors. ACGT is a non-profit organization dedicated exclusively to funding scient... -
UC Riverside-Led Study: Gene Therapy Reverses Fragile X Deficits, Restoring Brain Activity and Improving Behavior in Mouse Model
UCR News - UC Riverside USA Overview A University of California, Riverside-led study demonstrated that a gene therapy designed to replace a missing brain protein successfully restored normal brain activity and improved behavior in a mous... -
Qihan Biotech’s Universal Dual-Target Hypoimmune CAR-T Therapy QT-019B Receives FDA RMAT and Breakthrough Therapy Designations
PackGene Biotech China Overview Qihan Biotech's universal dual-target CAR-T therapy, QT-019B, has received both FDA Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy Designations (BTD). This off-the-shelf allogeneic ... -
University of Houston Researchers Discover Salt Significantly Enhances Lipid Nanoparticle Delivery Efficiency in Gene Therapy
University of Houston USA Overview University of Houston researchers have discovered that adding salt to lipid nanoparticles (LNPs) dramatically improves the intracellular delivery efficiency of mRNA vaccines and gene therapeutics. This ... -
FDA Unleashes Real-Time Clinical Trials: An AI-Driven Revolution for Faster Drug Development
ICON plc アイルランド Overview The U.S. FDA has launched its Real-time Clinical Trials (RTCT) initiative, a pivotal program designed to dramatically accelerate drug development. By enabling near real-time data sharing with regulators and...
